healthcare.digital April 21, 2024
Exec Summary
The average multiples in HealthTech M&A deals in 2024 have slightly increased compared to 2023, reflecting a more optimistic but still cautious approach by investors in the face of broader socio economic and political uncertainty.
As of April 2024, the average enterprise value (EV) to sales multiple is 4.8x, up from 4.5x in November 2023 and the average EV to EBITDA multiple range is 10x to 12.5x .
Here’s a breakdown of average multiples for different types of HealthTech companies in 2023:
Telehealth companies: 5.5x to 4.7x
Wellness companies: 4.0x to 3.2x
Drug discovery companies: 7.0x to 5.5x
Medical device companies: 5.0x to 4.0x
Healthcare IT companies: 3.5x...
Today's Sponsors
Today's Sponsor